Facebook Instagram Pinterest Reddit Tumblr X Youtube
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 218

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

A Closer Look at Definium’s Phase 3 LSD for GAD Readout

Who Gets to Heal?

Weekly Psychedelic Policy Briefing: August 23, 2026

Field Notes #4: Resilient Refiles, Definium’s Readout, HRSA’s RFI Responses, and J&J’s Neuroplastogen Bet

Weekly Psychedelic Policy Briefing – August 16, 2026

Psyched Wellness Announces Path to Market for AME-1-derived Products in the...

COMPASS Pathways announces changes in Executive Team

Awakn Life Sciences Reports Fiscal Third Quarter 2021 Financial Results and...

Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office...

Apeiron and Other Key Shareholders of atai Life Sciences Reinforce Support...

Editor’s Choice Award 2021-Best Study on Psychedelics and Neuroplasticity

Psyched Wellness Hires Del Mahabadi as Digital Marketing Consultant to Drive...

Silo Pharma, Inc. Engages Donohoe Advisory to Assist with its Efforts...

PharmaTher Announces Positive Research Results for LSD Microneedle Patch

Awakn Life Sciences Appoints Former EVP & Chief Commercial Officer of...

Load more

EDITOR PICKS

A Closer Look at Definium’s Phase 3 LSD for GAD Readout

Who Gets to Heal?

Weekly Psychedelic Policy Briefing: August 23, 2026

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    Facebook Instagram Pinterest Reddit Tumblr X Youtube
    ©